Evidence map›Paper›PMID 29712778›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2018

GDNF, Neurturin, and Artemin Activate and Sensitize Bone Afferent Neurons and Contribute to Inflammatory Bone Pain.

Sara Nencini, Mitchell Ringuet, Dong-Hyun Kim, Claire Greenhill, Jason J Ivanusic

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it, 96 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Artemin sensitises mouse (Mus musculus) and naked mole-rat (Heterocephalus glaber) sensory neurons in vitro.Journal of comparative physiology. A, Neuroethology, sensory, neural, and behavioral physiology · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sara NenciniDepartment of Anatomy and Neuroscience, University of Melbourne, Parkville 3010, Victoria, Australia.ORCID 0000-0002-3940-7700
Mitchell RinguetDepartment of Anatomy and Neuroscience, University of Melbourne, Parkville 3010, Victoria, Australia.ORCID 0000-0002-7890-307X
Dong-Hyun KimDepartment of Anatomy and Neuroscience, University of Melbourne, Parkville 3010, Victoria, Australia.
Claire GreenhillDepartment of Anatomy and Neuroscience, University of Melbourne, Parkville 3010, Victoria, Australia.
Jason J IvanusicDepartment of Anatomy and Neuroscience, University of Melbourne, Parkville 3010, Victoria, Australia j.ivanusic@unimelb.edu.au.ORCID 0000-0002-7413-5704
The University of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pain associated with skeletal pathology or disease is a significant clinical problem, but the mechanisms that generate and/or maintain it remain poorly understood. In this study, we explored roles for GDNF, neurturin, and artemin signaling in bone pain using male Sprague Dawley rats. We have shown that inflammatory bone pain involves activation and sensitization of peptidergic, NGF-sensitive neurons via artemin/GDNF family receptor α-3 (GFRα3) signaling pathways, and that sequestering artemin might be useful to prevent inflammatory bone pain derived from activation of NGF-sensitive bone afferent neurons. In addition, we have shown that inflammatory bone pain also involves activation and sensitization of nonpeptidergic neurons via GDNF/GFRα1 and neurturin/GFRα2 signaling pathways, and that sequestration of neurturin, but not GDNF, might be useful to treat inflammatory bone pain derived from activation of nonpeptidergic bone afferent neurons. Our findings suggest that GDNF family ligand signaling pathways are involved in the pathogenesis of bone pain and could be targets for pharmacological manipulations to treat it.

Indexed as

AnimalsBone and BonesBone DiseasesBone MarrowGlial Cell Line-Derived Neurotrophic FactorInflammationMaleNerve Tissue ProteinsNeurons, AfferentNeurturinPainRatsRats, Sprague-DawleySignal TransductionArtn protein, ratGdnf protein, ratGlial Cell Line-Derived Neurotrophic FactorNerve Tissue ProteinsNeurturinNrtn protein, ratarteminbone painGDNFneurturinpainskeletal pain

Identifiers

PMID29712778
PMCPMC6596122
OpenAlexW2799321382

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.